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Abstract
Grey matter (GM) damage is a clinically relevant feature of multiple sclerosis (MS) that has been previously assessed with
diffusion tensor imaging (DTI). Fractional anisotropy (FA) of the basal ganglia and thalamus might be increased in MS
patients, and correlates with disability scores. Despite the established role of the striatum and thalamus in motor control,
mood and cognition, the impact of DTI changes within these structures on motor and neuropsychological performance has
not yet been specifically addressed in MS. We investigated DTI metrics of deep GM nuclei and their potential association
with mobility and neuropsychological function. DTI metrics from 3T MRI were assessed in the caudate, putamen, and
thalamus of 30 MS patients and 10 controls. Sixteen of the patients underwent neuropsychological testing. FA of the
caudate and putamen was higher in MS patients compared to controls. Caudate FA correlated with Expanded Disability
Status Scale score, Ambulation Index, and severity of depressive symptomatology. Putamen and thalamus FA correlated
with deficits in memory tests. In contrast, cerebral white matter (WM) lesion burden showed no significant correlation with
any of the disability, mobility and psychometric parameters. Our findings support evidence of FA changes in the basal
ganglia in MS patients, as well as deep GM involvement in disabling features of MS, including mobility and cognitive
impairment. Deep GM FA appears to be a more sensitive correlate of disability than WM lesion burden.
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Introduction
In addition to the hallmark demyelinating white matter (WM)
lesions, grey matter (GM) damage in MS has been demonstrated
in the early histopathological descriptions of the disease [1,2] but
only recently has been characterized with modern neuroimaging
techniques. Newer MRI approaches have improved sensitivity to
detect cortical [3–6] and subcortical [7–9] GM abnormalities in
MS patients. These GM abnormalities can be detected at the early
stages of the disease [10,11], and are associated with physical
disability and cognitive impairment [12,13]. Volumetric MRI
studies showed that among cerebral GM regions, deep grey nuclei,
such as basal ganglia and thalamus, seem prominently susceptible
to neurodegeneration early in the course of the disease [14,15].
Moreover, subcortical atrophy showed stronger association with
cognitive performance than whole-brain atrophy [16]. DTI, a
MRI-based technique traditionally used for characterizing micro-
structural properties of WM tracts, has been recently employed in
a few studies to detect microstructural abnormalities in the deep
GM (Table 1) [17–23]. Increased tissue anisotropy of the basal
ganglia and the thalamus have been reported in relapsing-
remitting (RR) and secondary-progressive (SP) MS patients
[17,20–23]. The clinical relevance of these changes is supported
by their association with physical disability and disease duration
[23].
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e101199Striatal nuclei and the thalamus are critical nodes of
topographically organized connections between cortical and
subcortical areas involved in processing motor, affective and
cognitive information [24].
Here we report on DTI changes in the deep GM nuclei of MS
patients. To assess whether DTI GM abnormalities have a clinical
impact, we assessed associations of diffusion characteristics of the
caudate, putamen and thalamus with the Expanded Disability
Status Scale (EDSS) and gait (ambulation index (AI) and the
Timed 25-Foot Walk (T25-FW)). In a smaller number of subjects
we also performed a preliminary exploration of the relationship
between DTI findings and neuropsychological status.
Methods
Subjects and study design
Thirty patients with MS (25 RR and 5 SP) were consecutively
enrolled for this study (Table 2). Ten subjects with no neurological
symptoms or known major medical disorders were recruited as
controls. There was no significant difference in age and gender
distribution between the controls and MS patients (Table 2).
Inclusion criteria for MS patients were: 1) age 18–60; 2) diagnosis
of RRMS or SPMS [25]; 3) no history of other major medical
disorders; and 4) no relapse or corticosteroid use within 4 weeks
before MRI examination. All MS patients underwent a neurologic
examination by an MS specialist neurologist, including EDSS
scoring [26], and were treated with disease-modifying therapies
according to the standard of care. Detailed selection criteria for the
controls have been specified elsewhere [27].
The Institutional Review Board of the Brigham and Women’s
Hospital (Partners Healthcare Human Research Committee)
approved this study, and all subjects gave written informed
consent.
Functional Assessment
Gait performance of all MS patients was assessed using the AI
[28] and the T25-FW [29]. Sixteen MS patients (13 RR and 3 SP)
were administered the Minimal Assessment of Cognitive Function
in MS, a test battery designed to assess the cognitive domains most
commonly affected in MS [30]. They were also administered the
Center for Epidemiologic Studies Depression Scale [31] to assess
depressive symptoms. The Minimal Assessment of Cognitive
Function in MS battery consists of seven cognitive tests yielding 11
raw scores (see Table 3). The raw scores on cognitive measures
were converted into z-scores using the means and standard
deviations derived from a reference group of 20 control subjects
(different from the ten subjects included as control group for MRI
measurements) [32]. Any z-score #21.5 was considered impaired.
Patients were labeled as having overall neuropsychological
impairment if they demonstrated impairment on two or more
tests. Center for Epidemiologic Studies Depression Scale scores $
36 were considered to be in the depressed range. All clinical and
neuropsychological assessments were performed within 3 months
from the MRI scan at the Partners MS Center.
MRI acquisition
Whole head images were acquired on a 3T scanner (Signa; GE
Healthcare, Milwaukee, Wisconsin) using a head-only phased
array coil. Scans were obtained from all subjects using a research
protocol, including the following MRI sequences:
1) FLAIR: TR/TE/TI=9000/151/2250 ms, slice thickness
=2 mm (70 slices - no gap), matrix size =2566256, pixel size
=0.97660.976 mm, acquisition time =9 minutes, number of
signal averages =1.
2) DTI: TR/TE=13000/86 ms; slice thickness =3 mm (39
slices - no gap); pixel size =1.961.9 mm interpolated to
0.9760.97 during image reconstruction on the scanner; b-
factor =0 (5 averages) and 1000 s/mm
2 (repeated at 21
diffusion gradient directions).
Table 1. Summary of the previous most relevant studies showing DTI abnormalities in the grey matter in MS patients.
Reference Subjects Regions of Interest DTI Indices Results
Ciccarelli
et al., 2001 [17]
RRMS, SPMS, Ctrl Caudate head, putamen, thalamus,
hippocampus, cerebellar GM
(9-pixel square ROIs placed
bilaterally in each anatomical region)
FA, MD FA – MS(combined).Ctrl in the basal ganglia, putamen and
thalamus MD – Ctrl.MS(combined) in the putamen
Bozzali et al.,
2002 [18]
RRMS, PPMS, Ctrl Whole GM MD Ctrl.RRMS.PPMS
Vrenken et al.,
2006 [19]
RRMS, SPMS, PPMS, Ctrl Whole NAGM; bilateral ROIs
analysis of hippocampus,
and cingulate, frontal, insular,
parieto-occipital, striate cortex
FA, MD FA – MS(combined).Ctrl in whole NAGM, frontal, insular,
parieto-occipital and striate cortex; RRMS.SPMS in parieto-
occipital cortex; Ctrl.SPMS in hippocampus, frontal, insular,
parieto-occipital and striate cortex MD – MS(combined).
Ctrl in all ROIs; SPMS.PPMS.RRMS in insular cortex;
PPMS.RRMS in striate cortex
Hasan et al., 2009 [20] RRMS, Ctrl Caudate FA, MD FA and MD – RRMS.Ctrl
Hasan et al., 2011 [21] CIS, RRMS, SPMS, Ctrl Thalamus FA, MD, AD, RD MD – MS(combined).Ctrl
Hasan et al.,
2012 [22]
RRMS, Ctrl Cerebral cortical GM and deep
GM structures (as segmented
by FreeSurfer)
FA, MD, AD, RD FA, MD, AD, RD – RRMS.Ctrl in almost all the GM structures
analyzed
Hannoun et al.,
2012 [23]
RRMS, SPMS, Ctrl Caudate, thalamus FA, MD FA – RRMS.Ctrl and SPMS.Ctrl in both the caudate and
thalamus; SPMS.RRMS in both the caudate and thalamus
MD – RRMS.Ctrl and SPMS.Ctrl in the thalamus
Abbreviations: AD – axial diffusivity, CIS – clinically isolated syndrome, Ctrl – control, FA – fractional anisotropy, GM – grey matter, MD – mean diffusivity, MS – multiple
sclerosis, NAGM – normal-appearing grey matter, PPMS – primary progressive multiple sclerosis, RD – radial diffusivity, RRMS – relapsing-remitting multiple sclerosis.
doi:10.1371/journal.pone.0101199.t001
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DTI analysis. The FMRIB Diffusion Toolbox of FSL
(http://fsl.fmrib.ox.ac.uk) was used to correct for head motion
and eddy current distortion. DTI volumes were then spatially
aligned to a set of synthetic images generated by a first-pass
analysis of the data, as detailed hereafter. Following the method of
Bai and Alexander [33], an initial diffusion tensor map was
created using FSL software for eddy current correction and
Camino software (http://cmic.cs.ucl.ac.uk/camino) for diffusion
tensor calculation. Synthetic images for each diffusion direction
were generated from this initial map, and used as registration
targets for the original DTI images. Each DTI image was co-
registered to the corresponding synthetic image and resampled to
a1 6161 mm matrix, using IRTK software (www.doc.ic.ac.uk/
,dr/software). To limit resampling artifacts Gaussian interpola-
tion, with the smoothing kernel full-width at half maximum equal
to the acquisition matrix element size, was applied. The diffusion
tensor was then estimated using Levenburg–Marquardt optimiza-
tion with outlier rejection to remove artifacts such as signal loss
due to cardiac pulsation using Camino software [34]. After
diagonalization of the estimated tensor matrix, the fractional
anisotropy (FA), mean diffusivity (MD), and axial diffusivity (AD)
were calculated, using Camino.
Region of interest definition on DTI maps. The 3D extent
of the caudate head, the putamen and the thalamus was manually
outlined on AD maps using 3D Slicer (www.slicer.org) by two
trained physicians (MC, GW) blind to demographic and clinical
data (Figure 1). This approach has been previously validated by
direct comparison to a reference, automated method based on co-
registration of anatomical parcellation maps (obtained by applying
the FreeSurfer analysis pipeline to T1-weighted images) to the
DTI images [23]. Mean FA and MD of each region of interest
(ROI) (left and right combined) outlined by one of the two
physicians were included in the statistical analyses. For FA, intra-
rater intraclass correlation coefficient (r
2) was 0.96 for caudate,
0.94 for putamen and 0.96 for thalamus; inter-rater r
2 was 0.93 for
caudate, 0.92 for putamen and 0.92 for thalamus. To assess
whether the FA values were impacted by partial volume averaging
with surrounding tissue, we measured FA of the three structures of
interest after one- and two-pixel erosion of the ROIs in the control
group. The mean FA after one- or two-pixel erosion showed no
statistically significant difference from the raw (non-eroded) values
(Figure S1). Since the variance of the measured FA increased with
the number of pixels eroded, we opted to use the non-eroded
ROIs for our primary analysis. Dilation of the ROIs, on the other
hand, did affect the FA values significantly (Figure S1). Group
differences in caudate and putamen FA were demonstrated using
Table 2. Demographic, clinical and MRI characteristics.
Control (n=10) MS (n=30) p
Age [years; mean6SD (range)] 4169 (32–51) 4368 (28–57) 0.41
a
Gender [F/M] 7/3 18/12 0.57
b
Disease Category [RR/SP] - 25/5 -
Disease Duration [years; mean6SD (range)] - 11610 (1–35) -
EDSS [median (range)] - 1.5 (0–6.5) -
Ambulation Index [median (range)] - 1 (0–6) -
Timed 25-Foot Walk [s; mean6SD (range)] - 7.93612.41 (3–61) -
FLAIR lesion volume [ml; mean6SD (range)] - 9.6567.83 (2–30) -
aMann-Whitney test;
bChi-squared test.
doi:10.1371/journal.pone.0101199.t002
Table 3. The Minimal Assessment of Cognitive Function in MS battery: cognitive domains, neuropsychological tests and
component scores.
Cognitive Domains Neuropsychological Tests Component Scores
Processing speed/Working memory Paced Auditory Serial Addition Test 30 Total Score
20 Total Score
Symbol Digit Modalities Test Total Score
Learning and Memory California Verbal Learning Test-II Total Learning
Delayed Free Recall
Brief Visuospatial Memory Test-Revised Total Recall
Delayed Free Recall
Executive Functions Delis–Kaplan Executive Function System Free Sorting Test Total Confirmed Correct Sorts
Total Description Score
Visual perception/Spatial processing Judgment of Line Orientation Total Score
Language Controlled Oral Word Association Test Total Score
doi:10.1371/journal.pone.0101199.t003
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eroded ROIs (data not shown).
WM lesion volume measurement. One trained physicians
(MC) supervised by an expert in image analysis (AC), both blinded
to the clinical data, determined cerebral WM lesion volume on
FLAIR images [15,32] using a local-thresholding-based, semi-
automated edge-finding tool, and manual correction, in Jim 5
(www.xinapse.com) (Figure 1). FLAIR images were also reviewed
by two neuroimaging experts (MC, MN) to assess the presence of
MS lesions in the caudate, putamen and thalamus. No subject
showed lesions in the three deep gray matter structures of interest.
Statistical analysis
Statistical analysis was performed using SPSS 13 (SPSS Inc.,
Chicago, Illinois). Mann-Whitney and Chi-squared tests were used
to assess differences between patients and controls in age and
gender, respectively. Group differences in the DTI metrics
between MS patients and controls were analyzed by general
linear models, including age and gender as covariates. We
measured the association between quantitative MRI measures,
as well as between MRI and clinical parameters by Spearman’s
rho. Age- and gender-adjusted partial correlations were assessed
for the DTI variables that showed significant correlations with
clinical parameters. Analyses involving neuropsychological test
scores were also adjusted for educational status (partial correla-
tion). Throughout the analysis the threshold of significance was #
0.05. Due to the exploratory nature of the study, no correction was
made for the number of statistical tests.
Results
Subject demographics and relationship with DTI metrics
Demographic and clinical characteristics of the study popula-
tion are summarized in Table 2. No significant age or gender
differences were found between MS patients and controls.
FA values of the caudate, putamen and thalamus were normally
distributed (Figure S2), and intercorrelated (p,0.02). The striatal
structures showed similar FA values while the thalamus FA was
higher (Table 4; Figure 2). Among the three structures of interest,
the caudate showed the highest MD (Table 4; Figure 2). We found
no significant differences between left and right in the FA or MD
values of the three structures of interest. There was a correlation
between MD values in the caudate and putamen (rho=0.338,
p=0.035), but not between the MD of these two structures and
Figure 1. MRI example of white matter lesions and the segmented deep grey matter structures. Lesions and anatomical regions of
interest are illustrated on a set of MR images from a 53 year-old male MS patient. Left – axial FLAIR; right – axial diffusivity map. The output of
computer-assisted segmentation of the lesions is shown on FLAIR. The 3D models of the manually outlined caudate (green), putamen (blue) and
thalamus (red) are overlaid on the fractional anisotropy map of a single section containing these structures.
doi:10.1371/journal.pone.0101199.g001
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(p=0.043). We also found a positive correlation between both FA
and MD of the thalamus and age in the whole study population
(MS patients combined with controls) (rho=0.428, p=0.006 for
FA; rho=0.334, p=0.038 for MD; Figure S3). For thalamic FA
similar results were obtained also in the MS and control groups
separately. Due to these findings, and other published evidence of
age and gender influence on DTI characteristics of the deep GM
[35], we controlled for age and gender throughout the statistical
analyses.
DTI comparisons between MS patients and controls
FA of the caudate and putamen was higher in the MS patients
compared to controls (Figure 2; p=0.007 and p=0.048,
respectively), independently of age and gender. Subgroup analysis
comparing only RRMS patients and controls showed similar
results (Table 4). No significant differences between patients and
controls were observed in the FA of the thalamus and MD values
of all three structures of interest.
Relationship between MRI and clinical parameters in MS
patients
In MS patients caudate FA was positively correlated with EDSS
(r=0.424, p=0.022) and AI (r=0.388, p=0.037), independently
from age and gender (Figure 3). We found no significant
correlations between EDSS or AI and DTI metrics of the
putamen or thalamus. No significant association was found
between the T25-FW and DTI metrics in the caudate, putamen,
or thalamus.
Among the cognitively tested MS subgroup, 4 out of 16 patients
had overall neuropsychological impairment, 8/16 patients showed
impaired Controlled Oral Word Association Test scores, 5/16
Figure 2. Boxplots showing the distributions of fractional anisotropy and mean diffusivity values in the caudate, putamen and
thalamus in patients with multiple sclerosis (MS) and controls. The significant p-values for fractional anisotropy difference between the two
groups are reported (general linear model, controlling for age and gender). Thick lines inside the boxes indicate the median value. The whiskers
indicate the top and bottom quartiles. Circles are outliers. Fractional anisotropy is a scalar value between 0 and 1; Mean diffusivity is expressed in
mm
2/s.
doi:10.1371/journal.pone.0101199.g002
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Structure/DTI metric All subjects (n=40) Controls (n=10) RRMS+SPMS (n=30) RRMS (n=25) SPMS (n=5) p*
Caudate
FA 0.13960.017 0.12660.010 0.14360.017 0.14260.017 0.15060.011 0.007 (0.016)
MD 0.90360.022 0.90160.012 0.90560.025 0.90560.024 0.89960.034 0.632 (0.628)
Putamen
FA 0.13060.017 0.12060.013 0.13260.017 0.13260.015 0.13860.028 0.048 (0.035)
MD 0.82060.016 0.82160.011 0.82060.017 0.81960.018 0.82160.020 0.999 (0.748)
Thalamus
FA 0.27760.017 0.27860.022 0.27660.016 0.27460.016 0.28860.022 0.495 (0.456)
MD 0.84160.022 0.83160.013 0.84460.022 0.84060.020 0.86460.022 0.134 (0.247)
Data are expressed as mean6SD.
* p-values (general linear model) refer to comparison between all MS patients and controls.
Significance p-values for comparison between RR-MS patients and controls are reported in parentheses.
Abbreviations: Fractional Anisotropy (FA), Mean Diffusivity (MD), Multiple Sclerosis (MS), Relapsing Remitting
(RR), Secondary Progressive (SP). FA is a scalar value between 0 and 1. MD is expressed in mm
2/s.
doi:10.1371/journal.pone.0101199.t004
Figure 3. Scatterplots showing the observed significant correlations between fractional anisotropy (FA) of the three deep grey
matter structures of interest and other variables of clinical relevance. Caudate FA showed a positive correlation with the Expanded
Disability Status Scale (EDSS), Ambulation Index and depressive symptomatology as measured by the Center for Epidemiologic Studies Depression
scale (CES-D). Putamen FA showed a positive correlation with White Matter (WM) Lesion Volume, as well as an inverse correlation with the Brief
Visuospatial Memory Test-Revised (BVMT-R) Total Recall and Delayed Free Recall scores. Thalamus FA showed an inverse correlation with the Symbol
Digit Modalities Test (SDMT) and the California Verbal Learning Test-II (CVLT-II) Total Learning scores, as well as a positive correlation with the CES-D
score.
doi:10.1371/journal.pone.0101199.g003
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Sorting Total Correct Sorts scores indicating impaired executive
functions, 2/16 showed abnormal Brief Visuospatial Memory Test
- Revised Total Recall scores, 1/16 showed impaired performance
on the Symbol Digit Modalities Test, the Judgment of Line
Orientation test or the California Verbal Learning Test (2
nd
edition) Total Learning, none showed impaired working memory
as assessed by the Paced Auditory Serial Attention Test (both the 3
and 2-second versions). In addition, 5/16 MS patients had Center
for Epidemiologic Studies Depression Scale scores in the depressed
range. FA was higher in MS patients with overall neuropsycho-
logical impairment compared to those without, in the putamen
(p=0.050) and thalamus (p=0.027), but did not reach statistical
significance in the caudate (p=0.088). We found the following
correlations (Table 5; Figure 3): caudate and thalamus FA with
severity of depressive symptomatology; putamen and thalamus FA
with cognitive deficits in memory tests; and between thalamus FA
and attention deficits. After controlling for age, gender and
educational status only the following associations remained
significant: caudate FA and severity of depressive symptomatology
(r=0.604, p=0.038); putamen FA and Brief Visuospatial Memory
Test score (Brief Visuospatial Memory Test - Revised Delayed
Free Recall, r=20.710, p=0.010).
Cerebral FLAIR WM lesion burden correlated positively only
with putamen FA (r=0.397, p=0.030; Figure 3) and disease
duration (r=0.462, p=0.010), and did not correlate with any of
the disability, mobility and neuropsychological parameters (p-
values .0.1).
Discussion
The primary aim of this study was to assess microstructural
damage of the deep GM in MS patients using DTI and to explore
its association with clinical and neuropsychological measures.
Consistent with previous studies we found that MS patients
showed increased FA values in the caudate and putamen
compared to control subjects [17,20,23]. Increased tissue anisot-
ropy of the basal ganglia is thought to reflect microstructural GM
damage [17,20,23]. Interpretation of the observed DTI abnor-
malities in terms of their histological correlates is still debated.
Specifically, the GM damage may be either secondary to
inflammatory demyelination in the WM (e.g., via Wallerian
degeneration) or the result of processes involving primarily the
GM [10,36]. In both cases, FA would likely increase as a
consequence of damage to the GM nuclei. The association
between putamen FA and WM lesion volume would support the
former mechanism, i.e. a secondary, rather than a primary injury.
However, the lack of association of WM lesion volume with
caudate and thalamic FA does not support this hypothesis. These
interpretations are based on indirect evidence and remain
speculative. Previous studies have hypothesized different histo-
pathological substrates that may explain the FA increase in the
GM. Dendritic stripping, resulting in reduced barriers to diffusion
of water molecules within the GM nuclei, has been proposed as
possible contributor to the observed FA increase in deep GM
nuclei [20,23]. Iron accumulation has also been hypothesized as
histopathological substrate of increased FA on the basis of T2-
relaxometry data [20]. Future MRI-pathology correlation studies,
as well as further studies using iron-sensitive MRI sequences (e.g.,
T2*-weighted gradient-recalled echo MRI or susceptibility-
weighted imaging) are warranted to specifically address this issue.
We did not find differences in the MD values of the structures of
interest between patients and controls, or any correlations between
MD and clinical parameters. These findings are consistent with
previously reported higher sensitivity of FA compared to MD in
detecting deep GM abnormalities in patients with MS [23].
As a secondary aim of this study we investigated possible
associations between DTI changes in the deep GM structures and
clinical parameters of physical disability and gait impairment. In a
limited subset of patients, we also piloted a first exploratory
analysis of the possible association between DTI findings in deep
GM and neuropsychological performance. We found significant
associations between tissue anisotropy in the deep GM nuclei and
physical disability, gait and neuropsychological impairment in MS
patients. Increased caudate FA values have previously been
associated with higher disability scores [23], in line with our
positive correlation between caudate FA and EDSS scores. In
addition, we specifically addressed the impact of DTI changes in
deep GM structures on motor performance by investigating their
correlation with two measures of gait, i.e. the AI and T25-FW. In
the MS group, increased caudate FA correlated with impaired gait
as measured by the AI, but not with T25-FW. The relatively
Table 5. Spearman’s correlations between fractional anisotropy of the deep grey matter nuclei and neuropsychological status in
the cognitively tested MS subgroup (n=16).
Caudate FA rho (p) Putamen FA rho (p) Thalamus FA rho (p)
Brief Visuospatial Memory Test/Total Recall 20.074 (0.786) 20.545 (0.029) 20.310 (0.242)
Brief Visuospatial Memory Test/Delayed Free Recall 20.183 (0.497) 20.690 (0.003) 20.414 (0.111)
Center for Epidemiologic Studies Depression Scale 0.716 (0.002) 0.353 (0.180) 0.640 (0.008)
Controlled Oral Word Association Test 20.146 (0.590) 20.119 (0.660) 20.480 (0.060)
California Verbal Learning Test/Total Learning 20.191 (0.478) 20.250 (0.350) 20.666 (0.005)
California Verbal Learning Test/Long-Delayed Free Recall 0.089 (0.743) 20.068 (0.803) 20.290 (0.276)
Delis–Kaplan Executive Function System Free Sorting Test/Total Correct Sorts 20.200 (0.457) 20.405 (0.119) 20.251 (0.349)
Delis–Kaplan Executive Function System Free Sorting Test/Total Description 20.121 (0.655) 20.427 (0.099) 20.196 (0.466)
Judgment of Line Orientation 20.070 (0.797) 20.030 (0.913) 0.235 (0.381)
Paced Auditory Serial Addition Test 20.148 (0.585) 0.133 (0.624) 20.180 (0.505)
Symbol Digit Modalities Test 20.458 (0.074) 20.345 (0.191) 20.620 (0.010)
All values shown are not corrected for age and gender with statistical significance (p#0.05) indicated in bold. Values shown in italics are those that remained significant
after correction for age, gender and educational status.
doi:10.1371/journal.pone.0101199.t005
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reliability, together with the small size of the study sample may
explain this apparent discrepancy in our results.
The caudate and putamen, collectively referred to as the
neostriatum, represent the main input node of the basal ganglia
circuitry receiving glutamatergic fibers from the sensorimotor
cortex. The association between impaired motor function and
DTI abnormalities in the caudate is consistent with its physiolog-
ical role, while the lack of such correlation in the putamen is
surprising, given its relevance within the sensorimotor loop.
Beside the traditional role of basal ganglia in motor control, it is
now established that these structures are also involved in neural
networks underlying affective and cognitive functions. For
instance, lesions occurring along the connections between the
basal nuclei and the prefrontal cortex are responsible for
behavioral and cognitive disconnection syndromes [24]. We found
a correlation between increased caudate FA and depressed mood
as measured by a standardized self-administered scale evaluating
depressive symptomatology (Center for Epidemiologic Studies
Depression Scale). We also found an association between increased
FA in the putamen and in the thalamus and impaired performance
on neuropsychological tests assessing visuo-spatial and verbal
memory, the Brief Visuospatial Memory Test and California
Verbal Learning Test, respectively. Despite the established key
role of the basal ganglia and thalamus in the neural networks
involved in behavior and cognition, the impact of MRI
abnormalities in these structures on neuropsychological dysfunc-
tion has been pointed out only recently in patients with MS, and
has not yet been investigated by means of DTI targeting the deep
GM. Our results are consistent with previous studies showing an
association between deep GM MRI abnormalities (atrophy, T2
hypointensity) and neuropsychological findings [37–39]. Specifi-
cally, thalamic atrophy predicted impaired performance in tests
assessing several cognitive domains, including verbal learning and
memory [39]. T2 signal and volume abnormalities of the putamen
have been associated with executive function and information-
processing speed deficits [37,38] rather than memory impairment.
The association between putamen DTI abnormalities and
impaired performance on the Brief Visuospatial Memory Test
represents a novel finding that needs confirmation in larger
studies.
Unlike our previously published findings in a clinically and
demographically similar cohort [23], we were unable to reproduce
thalamic FA differences between MS patients and controls. Given
the coexistence of WM and GM within this structure, MS
pathology results in competing influences on diffusion tensor
signal, and it is therefore conceivable, that damaged thalami might
paradoxically exhibit normal FA as a result of concomitant FA
increase in damaged thalamic GM nuclei and FA decrease in
damaged thalamic WM. Nevertheless, this discrepancy between
our current and our previous study remains unexplained. Our
study also failed to reproduce the associations of caudate and
thalamus FA with WM lesion burden shown in other cohorts
[23,24], yet found a positive correlation between putamen FA and
WM lesion burden. However, the association between thalamic
FA and WM lesion volume is inconsistent throughout the studies
[21,23]. Demographics, disease duration, EDSS and WM lesion
burden of our MS patients were very similar to those published
previously [20,23]. While the lack of difference in thalamic FA
between MS patients and controls observed in our study may
explain the inconsistency of our results with regards to this
structure, we are unable to explain the discrepant results with
regards to the caudate.
We acknowledge the small sample size as main limitation of our
study. This may limit the general applicability of our findings,
especially those regarding exploratory analyses of the relationship
between DTI characteristics of the deep GM nuclei and
neuropsychological status. In addition, most of the subjects
showed scores within the normal range in the tests assessing both
mood and cognition. This issue may limit the clinical relevance of
our findings. Total WM lesion burden did not correlate with any
of the clinical and cognitive outcome measures, likely for the same
reasons. The threshold for significance applied throughout the
analyses of the present study was not taking into account the
number of comparisons performed.
Notwithstanding these limitations, our data support evidence of
deep GM abnormalities associated with disabling features of MS,
including mobility and cognitive impairment. Although larger
studies are needed, our findings suggest that FA changes in deep
GM provide a more sensitive correlate of motor disability than
WM lesion burden.
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Figure S1 Boxplots showing the effect of erosion and
dilation of the regions of interest (ROIs) on fractional
anisotropy values in the control group. Zero (0) indicates
the raw, non-eroded segmentation; 1- and 2-PE indicate one- and
two-pixel erosion, respectively; 1- and 2-PD indicate one- and two-
pixel dilation, respectively. Statistically significant differences with
respect to the raw segmentation are indicated with (*) (Kruskal-
Wallis and Dunn’s test for post-hoc comparisons). The mean FA
after one- or two-pixel erosion showed no statistically significant
difference from the raw (non-eroded) values; while dilation of the
ROIs affected the caudate and putamen FA values significantly.
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Figure S2 Histograms showing the distribution of
fractional anisotropy and mean diffusivity values in
our study population. Fractional anisotropy is a scalar value
between 0 and 1; Mean diffusivity is expressed in mm
2/s.
(PS)
Figure S3 Scatterplots showing the relationship be-
tween age (years) and the DTI indices of the three
structures of interest. Spearman’s correlation coefficient and
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expressed in mm
2/s.
(PS)
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